Kurs & Likviditet
Prenumeration
Kalender
2025-02-14 | Bokslutskommuniké 2024 |
2024-11-01 | Kvartalsrapport 2024-Q3 |
2024-08-30 | Kvartalsrapport 2024-Q2 |
2024-05-31 | Ordinarie utdelning IZAFE B 0.00 SEK |
2024-05-30 | Årsstämma 2024 |
2024-04-26 | Kvartalsrapport 2024-Q1 |
2024-02-09 | Bokslutskommuniké 2023 |
2023-12-21 | Extra Bolagsstämma 2024 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-12 | Kvartalsrapport 2023-Q1 |
2023-04-06 | Ordinarie utdelning IZAFE B 0.00 SEK |
2023-04-05 | Årsstämma 2023 |
2023-02-03 | Bokslutskommuniké 2022 |
2022-11-07 | Kvartalsrapport 2022-Q3 |
2022-10-05 | Extra Bolagsstämma 2022 |
2022-08-26 | Kvartalsrapport 2022-Q2 |
2022-06-15 | Ordinarie utdelning IZAFE B 0.00 SEK |
2022-06-14 | Årsstämma 2022 |
2022-04-29 | Kvartalsrapport 2022-Q1 |
2022-02-18 | Bokslutskommuniké 2021 |
2021-11-29 | Kvartalsrapport 2021-Q3 |
2021-09-23 | Extra Bolagsstämma 2021 |
2021-08-30 | Kvartalsrapport 2021-Q2 |
2021-06-28 | Årsstämma 2021 |
2021-06-15 | Ordinarie utdelning IZAFE B 0.00 SEK |
2021-04-29 | Kvartalsrapport 2021-Q1 |
2021-02-19 | Bokslutskommuniké 2020 |
2020-11-09 | Kvartalsrapport 2020-Q3 |
2020-08-17 | Kvartalsrapport 2020-Q2 |
2020-06-26 | Ordinarie utdelning IZAFE B 0.00 SEK |
2020-06-25 | Årsstämma 2020 |
2020-05-11 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-05-10 | Ordinarie utdelning IZAFE B 0.00 SEK |
2019-05-06 | Kvartalsrapport 2019-Q1 |
2019-04-10 | Årsstämma 2019 |
2019-02-28 | Bokslutskommuniké 2018 |
2018-12-18 | Extra Bolagsstämma 2018 |
2018-10-24 | Kvartalsrapport 2018-Q3 |
2018-08-29 | Kvartalsrapport 2018-Q2 |
2018-05-24 | Kvartalsrapport 2018-Q1 |
2018-04-12 | Ordinarie utdelning IZAFE B 0.00 SEK |
2018-04-11 | Årsstämma 2018 |
2018-03-22 | Bokslutskommuniké 2017 |
2017-08-29 | Kvartalsrapport 2017-Q2 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-04-26 | Ordinarie utdelning IZAFE B 0.00 SEK |
2017-04-25 | Årsstämma 2017 |
2017-02-24 | Bokslutskommuniké 2016 |
2016-11-16 | Kvartalsrapport 2016-Q3 |
2016-10-19 | Extra Bolagsstämma 2016 |
2016-08-31 | Kvartalsrapport 2016-Q2 |
2016-04-20 | Kvartalsrapport 2016-Q1 |
2016-02-25 | Ordinarie utdelning IZAFE B 0.00 SEK |
2016-02-24 | Årsstämma 2016 |
2016-02-04 | Bokslutskommuniké 2015 |
2015-11-13 | Kvartalsrapport 2015-Q3 |
2015-09-04 | Kvartalsrapport 2015-Q2 |
2015-07-22 | Extra Bolagsstämma 2015 |
2015-05-07 | Ordinarie utdelning IZAFE B 0.00 SEK |
2015-05-06 | Årsstämma 2015 |
2015-04-17 | Kvartalsrapport 2015-Q1 |
2015-02-20 | Bokslutskommuniké 2014 |
2014-12-17 | Extra Bolagsstämma 2014 |
2014-11-28 | Kvartalsrapport 2014-Q3 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-29 | Kvartalsrapport 2014-Q2 |
2014-06-12 | Ordinarie utdelning IZAFE B 0.00 SEK |
2014-06-11 | Årsstämma 2014 |
2014-05-16 | Kvartalsrapport 2014-Q1 |
2014-02-21 | Bokslutskommuniké 2013 |
2013-11-15 | Kvartalsrapport 2013-Q3 |
2013-08-28 | Kvartalsrapport 2013-Q2 |
2013-06-17 | Ordinarie utdelning IZAFE B 0.00 SEK |
2013-06-14 | Årsstämma 2013 |
2013-05-17 | Kvartalsrapport 2013-Q1 |
2013-02-22 | Bokslutskommuniké 2012 |
2012-11-30 | Kvartalsrapport 2012-Q3 |
2012-07-31 | Kvartalsrapport 2012-Q2 |
2012-06-20 | Ordinarie utdelning IZAFE B 0.00 SEK |
2012-06-19 | Årsstämma 2012 |
2012-04-20 | Kvartalsrapport 2012-Q1 |
2012-02-21 | Bokslutskommuniké 2011 |
2011-11-04 | Kvartalsrapport 2011-Q3 |
2011-08-12 | Kvartalsrapport 2011-Q2 |
2011-05-06 | Kvartalsrapport 2011-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Today, the Chairman of iZafe Group, Björn Rosengren, has acquired 500,000 Class B shares in the company, valued at 110,000 SEK (0.22 SEK per share.
In addition to today's transaction, Björn Rosengren also acquired 50,000 A-shares last week. Björn Rosengren now holds a total of 2,960,319 B-shares and 50,000 A-shares.
"I am pleased to increase my ownership in iZafe Group, which reflects my belief in the company's vision and potential," says Björn Rosengren. "These acquisitions demonstrate my continued commitment to supporting iZafe Group's strategic goals and creating value for its shareholders."
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafe.se/investor-relations/
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution and the connected dose bag Pilloxa. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafe.se/investor-relations/.